PFIZER INC.
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study Of Glasdegib In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The ICH Formulation
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-04-26
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT03130556
- Locations
- πΊπΈ
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 64
- Registration Number
- NCT03128411
- Locations
- π―π΅
Osaka City University Hospital, Osaka-City, Osaka, Japan
π―π΅Kindai University Hospital, Osaka-Sayama, Osaka, Japan
π―π΅NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan
Inotuzumab Ozogamicin - PF-05208773
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2020-05-18
- Lead Sponsor
- Pfizer
- Registration Number
- NCT03127605
Lorlatinib - PF-06463922
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2020-05-15
- Lead Sponsor
- Pfizer
- Registration Number
- NCT03127618
The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT03126721
- Locations
- π§πͺ
Pfizer Clinical Research Unit, Brussels, Belgium
First in Human Study for PF-06667272
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT03126149
- Locations
- π§πͺ
Pfizer Clinical Research Unit, Brussels, Belgium
A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 11
- Registration Number
- NCT03121664
- Locations
- π§πͺ
Pfizer Clinical Research Unit, Brussels, Belgium
Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 29
- Registration Number
- NCT03114540
- Locations
- πΊπΈ
OCRC, Orlando, Florida, United States
πΊπΈUniversity of Miami, Miami, Florida, United States
PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT03112148
- Locations
- πΊπΈ
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 7
- Registration Number
- NCT03100136
- Locations
- πΊπΈ
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
πΊπΈYale University School of Medicine, New Haven, Connecticut, United States
πΊπΈAnylan Center, New Haven, Connecticut, United States